MOMarika Oksanen

Marika Oksanen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marika Oksanen has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Distinct roles of COPI proteins attenuated in cell senescence

    by Krystyna Mazan-Mamczarz, Eleanor J. Wind, Apala Pal, Martin Salamini-Montemurri, Dimitrios Tsitsipatis, Kyoung Mi Kim, Rachel Munk, Jixiang Leng, Chang Hoon Shin, Jennifer L. Martindale, et al.

    In senescent cells, functional alterations in organelles like mitochondria and lysosomes are well characterized, but senescence-associated changes in Golgi function are not. An RNA interference screen revealed that silencing subunits of the coatomer protein I (COPI) complex, critical for intracellular transport involving the Golgi, reduced extracellular vesicle uptake. In proliferating WI-38 fibroblasts, silencing COPI constituents COPA, COPB1, COPB2, or COPD induced ATF4 production and disrupted autophagy, apoptosis, and cytokine signaling, all hallmarks of impaired Golgi–to–endoplasmic reticulum transport, while silencing COPI constituents COPG1, COPE, or COPZ1 altered the production of extracellular matrix proteins. Furthermore, individual COPI proteins associated with Golgi and endosomal proteins, supporting roles in vesicular trafficking. In senescent WI-38 fibroblasts, silencing COPI proteins did not elicit these phenotypes. Our findings underscore the distinct, multifunctional actions of individual COPI proteins and their key roles in intracellular homeostatic transport networks that become attenuated during senescence.

  • Open Access

    Transcriptomic-guided compound prioritization and proteomics validation for HNRNPU deficiency identify signalling correction

    by Xuan Ye, Diana Tikhomirova, Marika Oksanen, Massimiliano Gaetani, Hassan Gharibi, Francesca Mastropasqua, Kristiina Tammimies

    Heterogeneous nuclear ribonucleoprotein U (HNRNPU) deficiency is a rare genetic cause of neurodevelopmental disorders (NDDs) lacking targeted therapies. Here, we developed a transcriptomic-guided compound prioritization pipeline using Connectivity Map (CMap) analysis on multi-model transcriptomic signatures from HNRNPU -deficient human cells and mouse models. Ten compounds were selected through manual curation and functionally screened in patient-derived HNRNPU -deficient neuroepithelial stem (NES) cells with earlier observed cellular phenotypes. Two of the compounds, AS601245 and Lenalidomide, significantly reduced the elevated neural progenitor population during differentiation, and their combination further decreased primary cilia incidence, indicating partial rescue of the patient-specific cellular phenotypes. To understand the mechanisms underlying the partial rescue, we employed proteome integral solubility alteration (PISA) and expression proteomics. PISA assay identified TMEM150C and GSK3A as proximal targets of combined treatment. Additionally, we observed reversal of multiple biological pathways including downregulation of Wnt signalling and upregulation of mitochondrial pathways and transmembrane proteins. Altogether, we established a computational-experimental pipeline for transcriptomic-guided drug repurposing for a monogenic NDD, and demonstrated that the network-level modulation partially rescues the delayed neural differentiation in HNRNPU -deficient neural cells.

  • Open Access

    Elevated lysophosphatidylcholines during SSRI-induced neural differentiation correlate with early neurodevelopmental symptoms

    by Abishek Arora, Kristina Vacy, Cátia Marques, Mihai-Ovidiu Degeratu, Francesca Mastropasqua, Jenny Humphrey, Xuan Ye, Marika Oksanen, the Barwon Infant Study Investigator Group, Peter Vuillermin, et al.

    SUMMARY: Selective serotonin reuptake inhibitors (SSRIs) are often prescribed during pregnancy. Yet, epidemiological studies link in-utero SSRI exposure with neurodevelopmental disorders, such as autism and ADHD. The potential molecular mechanisms by which SSRIs impact early neurodevelopment are not fully understood. We exposed neuroepithelial stem cells derived from four human induced pluripotent stem cells lines to fluoxetine, citalopram, sertraline, and paroxetine. We then assessed cellular viability, reactive oxygen species (ROS) levels, mitochondrial function using adenosine triphosphate (ATP) assays, and performed high-throughput metabolomics at two timepoints: proliferation and neural differentiation stages. The key metabolic findings were validated in the in-vitro model and in a complementary population-based cohort, the Barwon Infant Study, consisting of 1074 mother-child pairs with analysed cord-blood metabolomes. Sertraline and paroxetine significantly decreased ROS and ATP levels, indicating mitochondrial alteration. Metabolomic profiling revealed consistent elevation of three lysophosphatidylcholines (LPCs 16:0, 18:0, 18:1) across all SSRIs except citalopram. We further observed elevated LPC levels in the cord blood of infants prenatally exposed to SSRIs, with a dose-dependent correlation to autism and ADHD-related symptoms at age two. Furthermore, the three LPCs modulated ROS and ATP levels in the neural cells. These findings provide insights into SSRI-induced molecular changes, highlight candidate metabolites that may warrant further investigation as indicators of SSRI exposure, and emphasise the need for exploring prenatal SSRI exposure effects and neurodevelopmental outcomes.


  • Open Access

    The role of HNRNPU-locus and circular RNAs in neuronal development and neurodevelopmental disorders

    by Marika Oksanen

    Neuronal development is a complex process regulated by precise gene expression programs involving chromatin organization, epigenetic modifications and RNA processing. Understanding these regulatory mechanisms is essential for elucidating how neural cells acquire and maintain their identity. In this thesis, the roles of RNA-binding protein HNRNPU and circular RNAs in regulating neuronal development were investigated using in vitro cell cultures and cortical organoids as model systems.In Study I, the focus was on examining the effects of HNRNPU deficiency on neural differentiation, RNA splicing, and 3D genome organization using a 2D in vitro model. HNRNPU deficiency was shown to cause significant disruptions in these processes. Genes that are localized in chromatin regions with differential 3D conformation and genes encoding mRNAs with differential splicing in HNRNPU- deficient cells were associated with neurodevelopmental disorders. Additionally, HNRNPU deficiency was shown to result in increased proportion of neural progenitors within differentiating neural populations. These disrupted trajectories highlight the importance of HNRNPU in maintaining genomic integrity and neural stem cell commitment to differentiation.The molecular interactome of HNRNPU during neural differentiation was investigated in Study II. Key regulatory networks associated with HNRNPU were identified using ribonucleoprotein immunoprecipitation, mass spectrometry and RNA sequencing. HNRNPU was found to, for example, interact with mammalian SWI/SNF chromatin remodeling complex, bringing new insights into the regulatory mechanisms behind chromatin organization defects seen in relation to HNRNPU deficiency. Identifying HNRNPU binding to mRNAs encoding DNA methylation regulators led to measuring global DNA methylation levels after HNRNPU silencing, revealing significant hypomethylation. This finding linked HNRNPU deficiency to the distinct methylation episignatures reported in individuals with HNRNPU- related neurodevelopmental disorders.The expression of circular RNAs during neural differentiation was explored in Study III. Key circular RNAs with increasing expression patterns were identified and validated. Interestingly, several circular RNAs were formed from linear mRNAs encoding proteins with synaptic functions, elucidating their possible regulatory roles and contributions to neurodevelopmental processes. Additionally, the exons within these circular RNAs had an increased frequency of genetic variation, and RNA-binding protein SFPQ was identified as a key regulator of these circular RNAs. The findings from this study provide an important resource for further research focusing on the roles of circular RNAs in neuronal development.In Unpublished results, the effects of different types of mutations affecting the HNRNPU-locus were investigated using a 3D cortical organoid in vitro model. New insights into the early gene expression regulation and epigenetic control exerted by HNRNPU were uncovered during neuronal development through single-cell RNA sequencing and DNA methylation arrays. Preliminary results revealed differences from different types of genetic variants in the HNRNPU-locus.Collectively, these studies enhance our understanding of the genetic and molecular basis of neurodevelopmental disorders. By elucidating the roles of HNRNPU and circular RNAs in neuronal development, we provide valuable knowledge of the roles of RNA-binding proteins and non-coding RNAs in orchestrating gene expression control during neuronal development.List of scientific papersI. Mastropasqua F.#, Oksanen M.#, Soldini C., Alatar S., Arora A., Ballarino R., Molinari M., Agostini F., Poulet A., Watts M.E., Rabkina I., Becker M., Li D., Anderlid B.M., Isaksson J., Lundin Remnelius K., Molsem M., Jacob Y., Falk A., Crosetto N., Bienko M., Santini E., Borgkvist A., Bölte S., Tammimies K. Deficiency of the Heterogeneous Nuclear Ribonucleoprotein U locus leads to delayed hindbrain neurogenesis. Biol Open. 2023 Oct 15;12(10):bio060113. https://doi.org/10.1242/bio.060113II. Oksanen M., Mastropasqua F., Mazan-Mamczarz K., Martindale J.L., Ye X., Arora A., Banskota N., Gorospe M., Tammimies K. Molecular interactome of HNRNPU reveals regulatory networks in neuronal differentiation and DNA methylation. BioRxiv. [Submitted; Preprint]https://doi.org/10.1101/2025.02.19.638869III. Watts M.E., Oksanen M., Lejerkrans S., Mastropasqua F., Gorospe M., Tammimies K. Circular RNAs arising from synaptic host genes during human neuronal differentiation are modulated by SFPQ RNA-binding protein. BMC Biol. 2023 May 26;21(1):127. https://doi.org/10.1186/s12915-023-01627-w# Denotes equal contribution

  • Open Access

    The role of HNRNPU-locus and circular RNAs in neuronal development and neurodevelopmental disorders

    by Marika Oksanen

    Neuronal development is a complex process regulated by precise gene expression programs involving chromatin organization, epigenetic modifications and RNA processing. Understanding these regulatory mechanisms is essential for elucidating how neural cells acquire and maintain their identity. In this thesis, the roles of RNA-binding protein HNRNPU and circular RNAs in regulating neuronal development were investigated using in vitro cell cultures and cortical organoids as model systems.In Study I, the focus was on examining the effects of HNRNPU deficiency on neural differentiation, RNA splicing, and 3D genome organization using a 2D in vitro model. HNRNPU deficiency was shown to cause significant disruptions in these processes. Genes that are localized in chromatin regions with differential 3D conformation and genes encoding mRNAs with differential splicing in HNRNPU- deficient cells were associated with neurodevelopmental disorders. Additionally, HNRNPU deficiency was shown to result in increased proportion of neural progenitors within differentiating neural populations. These disrupted trajectories highlight the importance of HNRNPU in maintaining genomic integrity and neural stem cell commitment to differentiation.The molecular interactome of HNRNPU during neural differentiation was investigated in Study II. Key regulatory networks associated with HNRNPU were identified using ribonucleoprotein immunoprecipitation, mass spectrometry and RNA sequencing. HNRNPU was found to, for example, interact with mammalian SWI/SNF chromatin remodeling complex, bringing new insights into the regulatory mechanisms behind chromatin organization defects seen in relation to HNRNPU deficiency. Identifying HNRNPU binding to mRNAs encoding DNA methylation regulators led to measuring global DNA methylation levels after HNRNPU silencing, revealing significant hypomethylation. This finding linked HNRNPU deficiency to the distinct methylation episignatures reported in individuals with HNRNPU- related neurodevelopmental disorders.The expression of circular RNAs during neural differentiation was explored in Study III. Key circular RNAs with increasing expression patterns were identified and validated. Interestingly, several circular RNAs were formed from linear mRNAs encoding proteins with synaptic functions, elucidating their possible regulatory roles and contributions to neurodevelopmental processes. Additionally, the exons within these circular RNAs had an increased frequency of genetic variation, and RNA-binding protein SFPQ was identified as a key regulator of these circular RNAs. The findings from this study provide an important resource for further research focusing on the roles of circular RNAs in neuronal development.In Unpublished results, the effects of different types of mutations affecting the HNRNPU-locus were investigated using a 3D cortical organoid in vitro model. New insights into the early gene expression regulation and epigenetic control exerted by HNRNPU were uncovered during neuronal development through single-cell RNA sequencing and DNA methylation arrays. Preliminary results revealed differences from different types of genetic variants in the HNRNPU-locus.Collectively, these studies enhance our understanding of the genetic and molecular basis of neurodevelopmental disorders. By elucidating the roles of HNRNPU and circular RNAs in neuronal development, we provide valuable knowledge of the roles of RNA-binding proteins and non-coding RNAs in orchestrating gene expression control during neuronal development.List of scientific papersI. Mastropasqua F.#, Oksanen M.#, Soldini C., Alatar S., Arora A., Ballarino R., Molinari M., Agostini F., Poulet A., Watts M.E., Rabkina I., Becker M., Li D., Anderlid B.M., Isaksson J., Lundin Remnelius K., Molsem M., Jacob Y., Falk A., Crosetto N., Bienko M., Santini E., Borgkvist A., Bölte S., Tammimies K. Deficiency of the Heterogeneous Nuclear Ribonucleoprotein U locus leads to delayed hindbrain neurogenesis. Biol Open. 2023 Oct 15;12(10):bio060113. https://doi.org/10.1242/bio.060113II. Oksanen M., Mastropasqua F., Mazan-Mamczarz K., Martindale J.L., Ye X., Arora A., Banskota N., Gorospe M., Tammimies K. Molecular interactome of HNRNPU reveals regulatory networks in neuronal differentiation and DNA methylation. BioRxiv. [Submitted; Preprint]https://doi.org/10.1101/2025.02.19.638869III. Watts M.E., Oksanen M., Lejerkrans S., Mastropasqua F., Gorospe M., Tammimies K. Circular RNAs arising from synaptic host genes during human neuronal differentiation are modulated by SFPQ RNA-binding protein. BMC Biol. 2023 May 26;21(1):127. https://doi.org/10.1186/s12915-023-01627-w# Denotes equal contribution

  • Open Access

    Molecular interactome of HNRNPU reveals regulatory networks in neuronal differentiation and DNA methylation

    by Marika Oksanen, Francesca Mastropasqua, Krystyna Mazan-Mamczarz, Jennifer L. Martindale, Xuan Ye, Abishek Arora, Nirad Banskota, Myriam Gorospe, Kristiina Tammimies

    HNRNPU is an RNA-binding protein with diverse roles in transcriptional and post-transcriptional regulation. Pathogenic genetic variants of HNRNPU cause a severe neurodevelopmental disorder (NDD), but the underlying molecular mechanisms are unclear. Here, we comprehensively investigate the HNRNPU molecular interactome by integrating protein-protein interaction (PPI) mapping, RNA target identification, and genome-wide DNA methylation profiling in human neuroepithelial stem cells and differentiating neural cells. We identified extensive HNRNPU-centered networks, including a strong association with the mammalian SWI/SNF chromatin-remodelling complex, and uncovered a previously unrecognized role in translation. We present evidence that HNRNPU associates with mRNAs encoding proteins important for neuronal development, including several linked to NDDs. Silencing HNRNPU reprogrammed methylation dynamics at regulatory regions, particularly at active and bivalent promoters of neurodevelopmental transcription factors. Integrative analysis across PPI, RNA, and methylome datasets identified 19 converging genes at all three molecular levels, including NDD genes within the SWI/SNF complex and RNA-processing machinery such as SYNCRIP . Together, these data showcase HNRNPU as a central coordinator of RNA metabolism and epigenetic remodelling during neural differentiation, linking RNA-binding, chromatin organization, and DNA methylation to the pathogenesis of HNRNPU-related NDDs.

  • Open Access

    Novel Human Induced Pluripotent Stem Cell‐Based Model for Retinal Pigment Epithelial Cells to Reveal Possible Disease Mechanisms for Macular Degeneration in Pseudoxanthoma Elasticum

    by Taina Viheriälä, Heidi Hongisto, Lyydia Saari, Marika Oksanen, Tanja Ilmarinen, Suvi Väärämäki, Hannu Uusitalo, Pasi Nevalainen, Heli Skottman

    Pseudoxanthoma elasticum (PXE) is a rare metabolic disease with autosomal recessive inheritance. The manifestation in PXE is represented by retinal complications, pseudoxanthomas of the skin folding areas, and arterial calcification. The retinal complications are caused by the calcification of Bruch’s membrane beneath retinal pigment epithelial cells (RPE) that can lead to retinal macular degeneration. The exact mechanism for the retinal pathophysiology is not known, and patients have variable symptoms and findings. Two induced pluripotent stem cell (hiPSC) lines from a patient carrying the common homozygous mutation c.3421C > T, p.Arg1141X in the ATP‐binding cassette transporter gene (ABCC6; OMIM264800) were established and fully characterized. Then, RPE cells were differentiated, and molecular and functional characterization was conducted as a comparison to healthy controls. Data demonstrated that PXE‐specific high‐quality hiPSC lines can be established from a skin biopsy regardless of the skin‐related disease phenotype and disease‐specific RPE differentiation is feasible. The molecular and functional assessment of the PXE‐specific RPE indicated increased pigmentation and reduced epithelial barrier functions as well as phagocytosis activity as compared to healthy controls. Although preliminary data, this indicates possible RPE‐dependent factors that might explain the individual vulnerability of the retinas for macular degeneration in PXE. Future validation of the novel findings with additional PXE patients will be important.

  • Open Access

    Deficiency of the Heterogeneous Nuclear Ribonucleoprotein U locus leads to delayed hindbrain neurogenesis

    by Francesca Mastropasqua, Marika Oksanen, Cristina Soldini, Shemim Alatar, Abishek Arora, Roberto Ballarino, Maya Molinari, Federico Agostini, Axel Poulet, Michelle Watts, et al.

    Genetic variants affecting Heterogeneous Nuclear Ribonucleoprotein U (HNRNPU) have been identified in several neurodevelopmental disorders (NDDs). HNRNPU is widely expressed in the human brain and shows the highest postnatal expression in the cerebellum. Recent studies have investigated the role of HNRNPU in cerebral cortical development, but the effects of HNRNPU deficiency on cerebellar development remain unknown. Here, we describe the molecular and cellular outcomes of HNRNPU locus deficiency during in vitro neural differentiation of patient-derived and isogenic neuroepithelial stem cells with a hindbrain profile. We demonstrate that HNRNPU deficiency leads to chromatin remodeling of A/B compartments, and transcriptional rewiring, partly by impacting exon inclusion during mRNA processing. Genomic regions affected by the chromatin restructuring and host genes of exon usage differences show a strong enrichment for genes implicated in epilepsies, intellectual disability, and autism. Lastly, we show that at the cellular level HNRNPU downregulation leads to an increased fraction of neural progenitors in the maturing neuronal population. We conclude that the HNRNPU locus is involved in delayed commitment of neural progenitors to differentiate in cell types with hindbrain profile.


  • Open Access

    Circular RNAs arising from synaptic host genes are modulated by SFPQ RNA-binding protein and increased during human neuronal differentiation

    by Michelle Watts, Marika Oksanen, Sanna Lejerkrans, Francesca Mastropasqua, Myriam Gorospe, Kristiina Tammimies

    Background: Circular RNAs (circRNAs) are emerging as a key component of the complex neural transcriptome implicated in brain development. However, the specific expression patterns and functions of circRNAs in human neuronal differentiation have not been explored. Results: Using total RNA sequencing analysis, we identified expressed circRNAs during the differentiation of human neuroepithelial stem (NES) cells into developing neurons and discovered that many circRNAs originated from host genes associated with synaptic function. Interestingly, when assessing population data, exons giving rise to circRNAs in our dataset had a higher frequency of genetic variants. Additionally, screening for RNA-binding protein sites identified enrichment of Splicing Factor Proline and Glutamine Rich (SFPQ) motifs in increased circRNAs, several of which were reduced by SFPQ knockdown and enriched in SFPQ ribonucleoprotein complexes. Conclusions: Our study provides an in-depth characterisation of circRNAs in a human neuronal differentiation model and highlights SFPQ as both a regulator and binding partner of circRNAs elevated during neuronal maturation.

  • Open Access

    Deficiency of the Heterogeneous Nuclear Ribonucleoprotein U locus leads to delayed hindbrain neurogenesis

    by Francesca Mastropasqua, Marika Oksanen, Cristina Soldini, Shemim Alatar, Abishek Arora, Roberto Ballarino, Maya Molinari, Federico Agostini, Axel Poulet, Michelle Watts, et al.

    Genetic variants affecting Heterogeneous Nuclear Ribonucleoprotein U (HNRNPU) have been identified in several neurodevelopmental disorders (NDDs). HNRNPU is widely expressed in the human brain and shows the highest postnatal expression in the cerebellum. Recent studies have investigated the role of HNRNPU in cerebral cortical development, but the effects of HNRNPU deficiency on cerebellar development remain unknown. Here, we describe the molecular and cellular outcomes of HNRNPU locus deficiency during in vitro neural differentiation of patient-derived and isogenic neuroepithelial stem cells with a hindbrain profile. We demonstrate that HNRNPU deficiency leads to chromatin remodeling of A/B compartments, and transcriptional rewiring, partly by impacting exon inclusion during mRNA processing. Genomic regions affected by the chromatin restructuring and host genes of exon usage differences show a strong enrichment for genes implicated in epilepsies, intellectual disability, and autism. Lastly, we show that at the cellular level. HNRNPU downregulation leads to altered neurogenesis and an increased fraction of neural progenitors in the maturing neuronal population. We conclude that, HNRNPU locus is involved in delayed commitment of neural progenitors to neuronal maturation in cell types with hindbrain profile.